M
Maja-Lisa Løchen
Researcher at University of Tromsø
Publications - 207
Citations - 14272
Maja-Lisa Løchen is an academic researcher from University of Tromsø. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 43, co-authored 171 publications receiving 10614 citations. Previous affiliations of Maja-Lisa Løchen include European Society of Cardiology & Australian Catholic University.
Papers
More filters
Journal ArticleDOI
N-Acetyl-β-d-Glucosaminidase Does Not Enhance Prediction of Cardiovascular or All-Cause Mortality by Albuminuria in a Low-Risk Population
Marit Dahl Solbu,Ingrid Toft,Maja-Lisa Løchen,Ellisiv B. Mathiesen,Bjørn Odvar Eriksen,Toralf Melsom,Inger Njølstad,Tom Wilsgaard,Trond Jenssen +8 more
TL;DR: The nonsignificant improvement of risk prediction does not support the clinical use of NAG ratio in cardiovascular risk assessment in a low-risk group and the cross-sectional associations between NAG and cardiovascular risk factors are studied.
Journal ArticleDOI
Haemoglobin predicts total mortality in a general young and middle-aged male population. The Tromsø Study.
TL;DR: A U‐shaped relationship between quintiles of haemoglobin and total mortality was found, most pronounced in smokers in a dose–response manner, but also present in non‐smokers.
Journal ArticleDOI
Left atrial diameter, left ventricle filling indices, and association with all-cause mortality: Results from the population-based Tromsø Study.
Michael Stylidis,Ekaterina Sharashova,Tom Wilsgaard,David A. Leon,David A. Leon,Geir Heggelund,Assami Rösner,Inger Njølstad,Maja-Lisa Løchen,Henrik Schirmer,Henrik Schirmer +10 more
TL;DR: To examine the associations between diastolic dysfunction indices and long‐term risk of all‐cause mortality in adults over 23‐year follow‐up, a large number of participants were recruited from across Europe.
Journal ArticleDOI
Age-specific atrial fibrillation incidence, attributable risk factors and risk of stroke and mortality: results from the MORGAM Consortium.
Bente Morseth,B Geelhoed,Allan Linneberg,Lars Johansson,Kari Kuulasmaa,Veikko Salomaa,Licia Iacoviello,S. Costanzo,Stefan Söderberg,Teemu J. Niiranen,Teemu J. Niiranen,Julie K K Vishram-Nielsen,Inger Njølstad,Tom Wilsgaard,Ellisiv B. Mathiesen,Maja-Lisa Løchen,Tanja Zeller,Stefan Blankenberg,Francisco Ojeda,Renate B. Schnabel +19 more
TL;DR: In this paper, the authors examined age-specific risk factor associations with incident atrial fibrillation and their attributable fraction in a large European cohort and aimed to examine risk of stroke and mortality in relation to new-onset AF across age.
Journal Article
Treatment of congestive heart failure
Marit Aarønæs,Dan Atar,Vernon V.S. Bonarjee,Torstein Gundersen,Maja-Lisa Løchen,Rune Mo,Eivind S.P. Myhre,Torbjørn Omland,Rønnevik Pk,Johnny Vegsundvåg,Arne Westheim +10 more
TL;DR: A revised programme for the treatment of congestive heart failure in Norway is presented, meant for primary, secondary and third line health care providers in Norway to reduce morbidity and mortality in the heart failure population.